Ibuprofeno (Arginina) Kern Pharma

Ibuprofen, the active ingredient in Ibuprofeno (Arginina) Kern Pharma, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for systemic use. It relieves pain, reduces fever, and diminishes inflammation in adults and children when appropriate.

GNH USA supplies Ibuprofeno (Arginina) Kern Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability, regulatory support, and responsive customer service across multiple regions.

Ibuprofen acts systemically to reduce inflammation and pain by inhibiting cyclo‑oxygenase enzymes, making it useful for several common conditions.

- Pain: Provides analgesic relief for mild to moderate acute pain such as headaches, dental pain, or musculoskeletal discomfort. - Fever: Lowers elevated body temperature associated with infections or inflammatory processes. - Inflammation: Decreases swelling and redness in conditions like sprains, strains, or minor injuries. - Arthritis: Alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis.

Ibuprofen may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Rash or mild skin irritation. - Elevated liver enzymes (asymptomatic).

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. - Acute kidney injury or worsening of chronic renal disease. - Hepatotoxicity with marked liver enzyme elevation. - Cardiovascular events including myocardial infarction or stroke.

When using ibuprofen, certain precautions help minimize risks and ensure safe therapy. - Assess gastrointestinal risk: avoid use in patients with active ulcers or a history of GI bleeding. - Use the lowest effective dose: limit duration to the shortest period needed for symptom control. - Avoid in known hypersensitivity: discontinue if rash, itching, or swelling occurs. - Caution in renal or hepatic impairment: monitor kidney and liver function during treatment. - Review concomitant anticoagulant or antiplatelet therapy: increased bleeding risk may require adjustment. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Ibuprofen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened risk of serious bleeding. - High‑dose aspirin: competitive inhibition of COX enzymes may reduce antiplatelet effect. - Selective COX‑2 inhibitors (e.g., celecoxib): additive gastrointestinal toxicity. - ACE inhibitors or ARBs: may diminish antihypertensive response and affect renal function. - Lithium: ibuprofen can increase lithium serum concentrations, risking toxicity.

Moderate Interactions (Monitor Closely): - Other NSAIDs: combined use raises gastrointestinal and renal adverse event risk. - Diuretics: may exacerbate fluid loss and renal impairment. - Methotrexate: ibuprofen can reduce renal clearance, increasing toxicity. - SSRIs (e.g., sertraline): combined use may increase bleeding tendency. - Beta‑blockers: potential for reduced antihypertensive effect.